Maze Therapeutics, Inc. - Common Stock - par value $0.001 per share (MAZE)

CUSIP: 578784100

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock - par value $0.001 per share
Shares outstanding
48,247,400
Total 13F shares
42,970,633
Share change
+4,153,172
Total reported value
$1,114,223,528
Price per share
$25.93
Number of holders
93
Value change
+$108,250,260
Number of buys
61
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 578784100?
CUSIP 578784100 identifies MAZE - Maze Therapeutics, Inc. - Common Stock - par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Maze Therapeutics, Inc. - Common Stock - par value $0.001 per share (MAZE) as of Q3 2025

As of 30 Sep 2025, Maze Therapeutics, Inc. - Common Stock - par value $0.001 per share (MAZE) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,970,633 shares. The largest 10 holders included TRV GP IV, LLC, Frazier Life Sciences Management, L.P., ARCH Venture Management, LLC, Deep Track Capital, LP, Alphabet Inc., a16z Capital Management, L.L.C., Matrix Capital Management Company, LP, VANGUARD GROUP INC, BlackRock, Inc., and VR ADVISER, LLC. This page lists 93 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.